Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Heat Shock Protein 47: A Novel Biomarker of Thrombosis Risk

NCT06731673 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT06731673
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06731673 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Heat Shock Protein 47: A Novel Biomarker of Thrombosis Risk
Lead sponsor
University of Aarhus
Phase
Observational
Overall status
Recruiting
Start date
December 9, 2024
Completion date
August 31, 2027
Enrollment
340 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction with st segment elevation, stroke (in patients with atrial fibrillation), venous thromboembolism (vte)